Intervention Review

Anti-vascular endothelial growth factor for neovascular glaucoma

  1. Arathi Simha1,*,
  2. Andrew Braganza1,
  3. Lekha Abraham1,
  4. Prasanna Samuel2,
  5. Kristina Lindsley3

Editorial Group: Cochrane Eyes and Vision Group

Published Online: 2 OCT 2013

Assessed as up-to-date: 11 JAN 2013

DOI: 10.1002/14651858.CD007920.pub2


How to Cite

Simha A, Braganza A, Abraham L, Samuel P, Lindsley K. Anti-vascular endothelial growth factor for neovascular glaucoma. Cochrane Database of Systematic Reviews 2013, Issue 10. Art. No.: CD007920. DOI: 10.1002/14651858.CD007920.pub2.

Author Information

  1. 1

    Christian Medical College, Department of Ophthalmology, Vellore, India

  2. 2

    Christian Medical College, Department of Biostatistics, Vellore, Tamil Nadu, India

  3. 3

    Johns Hopkins Bloomberg School of Public Health, Department of Epidemiology, Baltimore, Maryland, USA

*Arathi Simha, Department of Ophthalmology, Christian Medical College, Vellore, 632001, India. arathisimha@rediffmail.com.

Publication History

  1. Publication Status: New
  2. Published Online: 2 OCT 2013

SEARCH

Cited in:

CrossRef

This article has been cited by:

  1. 1
    Enyr S. Arcieri, Jayter S. Paula, Rodrigo Jorge, Kleyton A. Barella, Rafael S. Arcieri, Danilo J. Secches, Vital P. Costa, Efficacy and safety of intravitreal bevacizumab in eyes with neovascular glaucoma undergoing ahmed glaucoma valve implantation: 2-year follow-up, Acta Ophthalmologica, 2014, 92, 6